olaparib targets prostate cancer mutations Calcium-based binders, however, are associated with greater odds of all-cause mortality versus sevelamer. Phosphate-binder therapy does not reduce mortality ...

April 29, 2010 (Orlando, Florida) — Taking a proton pump inhibitor (PPI) with a phosphate binder might improve phosphorus control in patients on hemodialysis, according to a retrospective study ...

Phosphate Therapeutics, today announces that recruitment of subjects into PEACH, the first pivotal trial of PT20 in subjects with hyperphosphataemia related to dialysis dependent chronic kidney ...

The medication may represent a new treatment option for dialysis patients, researchers concluded. A team led by Rong Wang, MD, of Shandong Provincial Hospital in Shandong, China, analyzed 8 randomized ...